Xiaobo Xia
Impact in
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Intraocular Surgery and Lenses
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Glaucoma and retinal disorders 32
- Retinal Diseases and Treatments 25
- Intraocular Surgery and Lenses 7
-
- Retinopathy of Prematurity Studies 10
- Co-authors
- Andrew L. Kung (3 shared papers)Weitao Song (22 shared papers)Madeleine E. Lemieux (2 shared papers)Wei Li (1 shared paper)Myles Brown (1 shared paper)Jason S. Carroll (1 shared paper)Shuhong Wang (1 shared paper)Dan Ji (12 shared papers)
- Journals
- BMC Ophthalmology (4 papers)Journal of Cellular Physiology (4 papers)Medicine (4 papers)Frontiers in Medicine (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaobo Xia
119 papers receiving 2.4k citations
Xiaobo Xia's Hit Papers
Peers
Comparison fields: 5 of 94
- Ophthalmology 805
- Cancer Research 331
- Molecular Biology 817
- Radiology, Nuclear Medicine and Imaging 212
- Pharmaceutical Science 39
Countries citing papers authored by Xiaobo Xia
This map shows the geographic impact of Xiaobo Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Xia more than expected).
Fields of papers citing papers by Xiaobo Xia
This network shows the impact of papers produced by Xiaobo Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Xia. The network helps show where Xiaobo Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 347 | |
| 2 | 2012 | 148 | |
| 3 | 2009 | 113 | |
| 4 | GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma Hit paper breakdown → | 2022 | 108 |
| 5 | 2019 | 79 | |
| 6 | 2019 | 71 | |
| 7 | 2001 | 68 | |
| 8 | 2019 | 54 | |
| 9 | 2019 | 51 | |
| 10 | 2020 | 46 | |
| 11 | 2022 | 44 | |
| 12 | 2022 | 44 | |
| 13 | 2020 | 37 | |
| 14 | 2013 | 34 | |
| 15 | 2018 | 33 | |
| 16 | 2019 | 33 | |
| 17 | 2020 | 33 | |
| 18 | 2022 | 33 | |
| 19 | 2009 | 31 | |
| 20 | 2019 | 30 |
About Xiaobo Xia
Xiaobo Xia is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Cell Biology and Pharmaceutical Science, having authored 124 papers that have together received 2.5k indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (32 papers), Retinal Diseases and Treatments (25 papers), Retinal Development and Disorders (23 papers), Retinopathy of Prematurity Studies (10 papers), Intraocular Surgery and Lenses (7 papers), Angiogenesis and VEGF in Cancer (7 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Ophthalmology (805 citations), Cancer Research (331 citations), Molecular Biology (817 citations), Radiology, Nuclear Medicine and Imaging (212 citations) and Pharmaceutical Science (39 citations). Xiaobo Xia has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Andrew L. Kung, Weitao Song, Madeleine E. Lemieux, Wei Li, Myles Brown, Jason S. Carroll, Shuhong Wang, Dan Ji, Haibo Li and Hui-zhuo Xu. Their work appears in journals such as BMC Ophthalmology, Journal of Cellular Physiology, Medicine, Frontiers in Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.